Publications
- New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis2023 | First Faculty of Medicine, Second Faculty of Medicine
- Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma2023 | First Faculty of Medicine
- A EUFOREA comment on a lost comorbidity of asthma2023 | First Faculty of Medicine
- Dysfunctional mucociliary clearance in asthma and airway remodeling - New insights into an old topic2023 | First Faculty of Medicine
- Asthma in the era of COVID-192023 | First Faculty of Medicine
- Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients2022 | First Faculty of Medicine
- Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank2021 | First Faculty of Medicine, Second Faculty of Medicine
- Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases-An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)2021 | First Faculty of Medicine
- Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases2021 | First Faculty of Medicine
- Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps2021 | First Faculty of Medicine
Loading network view...